BNP Paribas Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-572,437
Closed -$35.6M 904
2023
Q4
$35.6M Buy
572,437
+46,296
+9% +$2.59M 0.1% 230
2023
Q3
$29.5M Buy
526,141
+13,307
+3% +$749K 0.09% 237
2023
Q2
$25.9M Sell
512,834
-41,494
-7% -$2.21M 0.08% 249
2023
Q1
$30.2M Buy
554,328
+78,727
+17% +$4.6M 0.1% 211
2022
Q4
$29.7M Buy
475,601
+50,382
+12% +$3.34M 0.11% 224
2022
Q3
$30M Sell
425,219
-11,137
-3% -$768K 0.12% 202
2022
Q2
$24.7M Buy
436,356
+33,836
+8% +$1.86M 0.09% 245
2022
Q1
$25.2M Buy
402,520
+25,846
+7% +$1.39M 0.09% 266
2021
Q4
$21.1M Buy
376,674
+40,850
+12% +$2.5M 0.07% 310
2021
Q3
$21.9M Buy
335,824
+221,458
+194% +$15.1M 0.08% 275
2021
Q2
$7.25M Buy
+114,366
New +$6.75M 0.03% 487

Other funds holding AXNX

BNP Paribas Asset Management's AXNX Position: Q1 2024 in Review

BNP Paribas Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 572,437 shares — an estimated $35.6M sold.

BNP Paribas Asset Management first reported a position in AXNX in Q2 2021 and held it in 11 quarters. The position peaked at $35.6M in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • BNP Paribas Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • BNP Paribas Asset Management sold 572,437 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $35.6M.
  • BNP Paribas Asset Management first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • BNP Paribas Asset Management's Axonics, Inc. Common Stock position peaked at $35.6M in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on BNP Paribas Asset Management's 13F filing for Q1 2024, filed 8 May 2024.